Catalogue en ligne Bibliothèque du FARES

0

Document: texte imprimé

Pharmacological interventions for the treatment of smokeless tobacco use / Jon O. Ebbert (2012)

Public

Titre :	Pharmacological interventions for the treatment of smokeless tobacco use
Type de document :	texte imprimé
Auteurs :	Jon O. Ebbert, Auteur ; Karl Fagerström, Auteur
Editeur :	Adis International
Année de publication :	2012
Collection :	CNS Drugs, ISSN 1172-7047 num. Vol. 26
Importance :	10 p.
Présentation :	tab.
Langues :	Anglais (eng)
Catégories :	[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:bupropion [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotinique [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline
Index. décimale :	TA 6.2.3 Approche pharmacologique
Résumé :	Smokeless tobacco (SLT) is used in a variety of forms throughout the world. Long-term SLT use is associated with adverse health consequences. Effective pharmacotherapies are needed to treat SLT users who want to achieve tobacco abstinence. In the current review, we discuss the pharmacological interventions identified in a recent meta-analysis of interventions for SLT users, with inclusion of additional articles identified by searching PubMed up to August 2011. Nicotine replacement therapy (NRT) has been demonstrated to increase short-term tobacco abstinence rates and to alleviate craving and withdrawal symptoms among SLT users trying to quit. Bupropion sustained release has been shown to decrease craving and attenuate post-cessation weight gain among SLT users trying to quit. Varenicline is the only available medication demonstrated to increase long-term (≥6 months) tobacco abstinence rates among SLT users. Overall, findings from studies investigating pharmacotherapies for SLT users have been relatively disappointing. SLT reduction interventions may hold some promise for increasing abstinence rates among SLT users not interested in quitting. Additional investigations of higher dose NRT and combination pharmacotherapy are needed to advance the treatment of SLT users.
Permalink :	https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7959

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 005500	TA 6.2.3 EBB P	Article/Périodique	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Bibliothèque du FARES

Bibliothèque du FARES

A-
A
A+

Adresse

Bibliothèque du FARES
Rue Haute, entrée 290 / 807A
1000 Bruxelles
Belgique

02 518 18 74

Localisation et itinéraire

contact

Accueil

Se connecter

Mot de passe oublié ?
Pas encore inscrit ?